Observational studyBMJ open2026

Comparative risk of the neurodegenerative outcomes between sodium-glucose co-transporter 2 (SGLT2) inhibitors and thiazolidinediones in type 2 diabetes: a multicentre cohort study using the Korean healthcare database (2014-2025).

Sang Joon Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.